Edgardo Delfino Carosella
#160,972
Most Influential Person Now
Edgardo Delfino Carosella's AcademicInfluence.com Rankings
Edgardo Delfino Carosellabiology Degrees
Biology
#12745
World Rank
#16241
Historical Rank
Biotechnology
#225
World Rank
#227
Historical Rank
Immunology
#857
World Rank
#880
Historical Rank
Download Badge
Biology
Why Is Edgardo Delfino Carosella Influential?
(Suggest an Edit or Addition)Edgardo Delfino Carosella's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells (2008) (983)
- Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. (1997) (691)
- HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. (1998) (440)
- IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. (1999) (424)
- The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. (2003) (369)
- HLA-G: from biology to clinical benefits. (2008) (362)
- HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. (2003) (356)
- The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? (1997) (345)
- HLA-G2, -G3, and -G4 Isoforms Expressed as Nonmature Cell Surface Glycoproteins Inhibit NK and Antigen-Specific CTL Cytolysis1 (2001) (336)
- Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism (2001) (327)
- Beyond the increasing complexity of the immunomodulatory HLA-G molecule. (2008) (318)
- Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. (2000) (316)
- HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. (1999) (316)
- HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. (2004) (310)
- HLA-G: An Immune Checkpoint Molecule. (2015) (287)
- HLA‐G up‐regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells (2005) (275)
- Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. (2006) (267)
- NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. (2005) (253)
- HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? (2005) (247)
- Expression of HLA-G in human cornea, an immune-privileged tissue. (2003) (243)
- Human Leukocyte Antigen-G Expression After Heart Transplantation Is Associated With a Reduced Incidence of Rejection (2002) (240)
- An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. (1994) (233)
- Trogocytosis‐based generation of suppressive NK cells (2007) (228)
- Implication of HLA-G molecule in heart-graft acceptance (2000) (224)
- HLA-G: a shield against inflammatory aggression. (2001) (193)
- A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G. (2015) (193)
- Fetal DNA in skin of polymorphic eruptions of pregnancy (1998) (192)
- HLA-G inhibits the allogeneic proliferative response. (1999) (190)
- The genetic structure of 3′untranslated region of the HLA-G gene: polymorphisms and haplotypes (2010) (186)
- Specific activation of the non‐classical class I histocompatibility HLA‐G antigen and expression of the ILT2 inhibitory receptor in human breast cancer (2002) (183)
- Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6—STAT3 signaling pathway (2008) (181)
- Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule (2002) (177)
- Polymorphic Sites at the 3’ Untranslated Region of the HLA-G Gene Are Associated with Differential hla-g Soluble Levels in the Brazilian and French Population (2013) (174)
- Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease (2001) (173)
- The immunosuppressive molecule HLA-G and its clinical implications (2012) (173)
- Evidence to Support the Role of HLA-G5 in Allograft Acceptance through Induction of Immunosuppressive/ Regulatory T Cells1 (2006) (170)
- Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. (2003) (168)
- HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. (2001) (166)
- Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. (2001) (163)
- Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. (2003) (159)
- HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? (2001) (158)
- HLA-G gene repression is reversed by demethylation (2003) (152)
- Biology and functions of human leukocyte antigen-G in health and sickness. (2003) (152)
- Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. (1999) (151)
- Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. (2004) (148)
- CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. (2007) (145)
- HLA-G is a Crucial Immunosuppressive Molecule Secreted by Adult Human Mesenchymal Stem Cells (2009) (143)
- In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes. (2009) (142)
- Soluble HLA-G Inhibits Cell Cycle Progression in Human Alloreactive T Lymphocytes1 (2004) (137)
- HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. (2000) (136)
- Binding of HLA-G to ITIM-Bearing Ig-like Transcript 2 Receptor Suppresses B Cell Responses (2014) (128)
- Exosomes bearing HLA-G are released by melanoma cells. (2003) (127)
- Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA‐G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients (2004) (127)
- Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link. (1995) (126)
- HLA-G: a tolerance molecule from the major histocompatibility complex. (1999) (125)
- Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. (2005) (123)
- Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17. (2011) (123)
- HLA-G revisited. (1996) (122)
- Soluble HLA‐G Expression and Renal Graft Acceptance (2006) (120)
- Accelerated telomere shortening and telomerase activation in Fanconi's anaemia (1999) (119)
- A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β* (2001) (118)
- Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. (2003) (117)
- Modulation of HLA-G Expression in Human Neural Cells after Neurotropic Viral Infections (2005) (113)
- HLA-G in cancer: a way to turn off the immune system. (2003) (112)
- ILT2/HLA‐G interaction impairs NK‐cell functions through the inhibition of the late but not the early events of the NK‐cell activating synapse (2010) (110)
- Hypoxia modulates HLA-G gene expression in tumor cells. (2007) (108)
- HLA-G and HLA-E: fundamental and Pathophysiological aspects. (2000) (106)
- Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. (2007) (103)
- Non-classical transcriptional regulation of HLA-G: an update (2009) (100)
- The Dual Role of HLA-G in Cancer (2014) (100)
- Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts. (1995) (99)
- HLA-G Gene Polymorphism in Human Placentas: Possible Association of G*0106 Allele with Preeclampsia and Miscarriage (2008) (98)
- MICA triggering signal for NK cell tumor lysis is counteracted by HLA‐G1‐mediated inhibitory signal (2002) (97)
- A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. (2001) (96)
- Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines (2000) (94)
- Skin carcinoma arising from donor cells in a kidney transplant recipient. (2005) (94)
- NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G (2008) (93)
- Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA‐G expression correlates with malignant transformation, high inflammatory infiltration and HLA‐A1 genotype (2004) (91)
- The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells. (2011) (91)
- Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells. (2006) (89)
- HLA-G-dependent suppressor cells: Diverse by nature, function, and significance. (2008) (88)
- A highly sensitive polymerase chain reaction method reveals the ubiquitous presence of maternal cells in human umbilical cord blood. (1995) (88)
- Search for maternal cells in human umbilical cord blood by polymerase chain reaction amplification of two minisatellite sequences (1994) (85)
- The immunotolerance role of HLA-G. (1999) (83)
- Modulation of HLA-G expression in human thymic and amniotic epithelial cells. (2000) (82)
- HLA‐G in Transplantation: A Relevant Molecule for Inhibition of Graft Rejection? (2003) (79)
- HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. (2000) (79)
- Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. (2010) (79)
- Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts. (2001) (78)
- Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease. (2004) (78)
- Search for maternal cells in human umbilical cord blood by polymerase chain reaction amplification of two minisatellite sequences. (1994) (74)
- HLA-G expression in atopic dermatitis. (2001) (74)
- Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. (1999) (73)
- Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways. (2007) (72)
- Molecular mechanisms controlling constitutive and IFN-gamma-inducible HLA-G expression in various cell types. (1999) (71)
- Quantification and identification of soluble HLA-G isoforms. (2007) (69)
- Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors (2012) (69)
- RREB-1 Is a Transcriptional Repressor of HLA-G1 (2009) (68)
- HLA-G Expression in Human Embryonic Stem Cells and Preimplantation Embryos (2011) (68)
- Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. (2007) (68)
- Research on HLA-G: an update. (2007) (65)
- In vivo evidence that secretion of HLA‐G by immunogenic tumor cells allows their evasion from immunosurveillance (2014) (65)
- Immunohistochemical Study of HLA‐G Expression in Lung Transplant Recipients (2009) (61)
- Osteodifferentiated Mesenchymal Stem Cells from Bone Marrow and Adipose Tissue Express HLA-G and Display Immunomodulatory Properties in HLA-Mismatched Settings: Implications in Bone Repair Therapy (2014) (61)
- HLA-G expression in human melanoma cells: protection from NK cytolysis. (1999) (60)
- Telomerase activity during the cell cycle and in gamma-irradiated hematopoietic cells (1997) (59)
- Role of HLA‐G as a Predictive Marker of Low Risk of Chronic Rejection in Lung Transplant Recipients: A Clinical Prospective Study (2015) (59)
- Tolerogenic Functions of Human Leukocyte Antigen G: From Pregnancy to Organ and Cell Transplantation (2007) (59)
- The tolerogenic molecule HLA-G. (2011) (59)
- HLA-G*0105N Null Allele Encodes Functional HLA-G Isoforms1 (2005) (58)
- Molecular and Immunologic Aspects of the Nonclassical HLA Class I Antigen HLA‐G: Evidence for an Important Role in the Maternal Tolerance of the Fetal Allograft (1998) (58)
- HLA‐G gene activation in tumor cells involves cis‐acting epigenetic changes (2005) (58)
- Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study. (2013) (57)
- Switch of HLA‐G alternative splicing in a melanoma cell line causes loss of HLA‐G1 expression and sensitivity to NK lysis (2005) (57)
- Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology. (2005) (56)
- Novel landscape of HLA‐G isoforms expressed in clear cell renal cell carcinoma patients (2017) (56)
- Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy. (2007) (55)
- Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction (2012) (55)
- Intercellular exchanges of membrane patches (trogocytosis) highlight the next level of immune plasticity. (2006) (55)
- BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity. (1994) (53)
- Inhibition of human Vγ9Vδ2 T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer (2011) (52)
- Concise review: Combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy (2013) (52)
- Analysis of the role of HLA-G in preeclampsia. (2000) (52)
- HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus (2009) (49)
- Exchanges of membrane patches (trogocytosis) split theoretical and actual functions of immune cells. (2007) (49)
- Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer. (2008) (48)
- Dendritic Cells Secrete the Immunosuppressive HLA-G Molecule upon CTLA4-Ig Treatment: Implication in Human Renal Transplant Acceptance1 (2009) (47)
- Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2 (2016) (47)
- Kidney Transplant Recipients Treated With Belatacept Exhibit Increased Naïve and Transitional B Cells (2014) (47)
- HLA‐G1 and HLA‐G5 active dimers are present in malignant cells and effusions: The influence of the tumor microenvironment (2012) (46)
- Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology. (2009) (46)
- Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients. (2008) (46)
- Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection. (2009) (44)
- HLA-G 1-expressing antigen-presenting cells induce immunosuppressive CD 4 T cells (2004) (44)
- Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-κB inducers (2006) (42)
- Indoleamine 2,3 dioxygenase and human leucocyte antigen‐G inhibit the T‐cell alloproliferative response through two independent pathways (2005) (42)
- CD8+PD-1–ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G (2019) (41)
- Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line. (2001) (41)
- HLA-G gene polymorphism segregation within CEPH reference families (1997) (40)
- Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue Maintain Their Immunosuppressive Properties After Chondrogenic Differentiation: Role of HLA-G. (2016) (40)
- Functions of HLA-G in the immune system. (2007) (39)
- HLA-G expression: immune privilege for tumour cells? (1999) (39)
- Genetic and epigenetic features in radiation sensitivity (2005) (38)
- Linking Two Immuno-Suppressive Molecules: Indoleamine 2,3 Dioxygenase Can Modify HLA-G Cell-Surface Expression1 (2005) (37)
- Different functional outcomes of intercellular membrane transfers to monocytes and T cells (2010) (37)
- Immunotolerant functions of HLA-G (1999) (36)
- Multicolor flow cytometry analysis of blood cell subsets in patients given total body irradiation before bone marrow transplantation. (1995) (36)
- Haplotypes of the HLA-G 3’ Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially (2017) (36)
- Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4 (2017) (34)
- Synthetic HLA‐G proteins for therapeutic use in transplantation (2013) (34)
- Evidence for the presence of the alternatively spliced HLA-G mRNA forms in human mononuclear cells from peripheral blood and umbilical cord blood. (1995) (33)
- Selective expression of HLA‐G in malignant and premalignant skin specimens in kidney transplant recipients (2003) (33)
- HLA-G Expression in the Skin of Patients with Systemic Sclerosis (2009) (33)
- HLA-G gene transcriptional regulation in trophoblasts and blood cells: differential binding of nuclear factors to a regulatory element located 1.1 kb from exon 1. (1997) (32)
- Nitric oxide produces HLA‐G nitration and induces metalloprotease‐dependent shedding creating a tolerogenic milieu (2009) (32)
- Radiation-enhanced expression of interferon-inducible genes in the KG1a primitive hematopoietic cell line (1997) (31)
- Soluble human leukocyte antigen-G5 in septic shock: Marked and persisting elevation as a predictor of survival (2007) (31)
- HLA-G protein processing and transport to the cell surface (2002) (31)
- HLA-G promotes immune tolerance. (2000) (31)
- Genetic and epigenetic features in radiation sensitivity Part I: cell signalling in radiation response. (2005) (30)
- Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell. (2009) (30)
- HLA-G and cancer. (2007) (30)
- Proper Regrafting of Ig-Like Transcript 2 after Trogocytosis Allows a Functional Cell–Cell Transfer of Sensitivity (2011) (30)
- HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera (2008) (29)
- HLA-G expression in trophoblast cells is independent of embryonic development. (2000) (28)
- Viewpoint on the Functionality of the Human Leukocyte Antigen-G Null Allele at the Fetal-Maternal Interface (2002) (28)
- Implication of HLA-G in human embryo implantation. (2007) (28)
- HLA-G and HLA-E: fundamental and pathophysiological aspects. (2000) (27)
- Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA. (1999) (27)
- Polymorphism of HLA-G gene and protein. (1999) (27)
- HLA-G 2012 conference: the 15-year milestone update. (2013) (26)
- Expression of HLA-G in cancer bladder. (2005) (26)
- In vivo, RFX5 binds differently to the human leucocyte antigen‐E, ‐F, and ‐G gene promoters and participates in HLA class I protein expression in a cell type‐dependent manner (2004) (25)
- Microchimerism in human diseases. (2000) (25)
- Membrane redistributions through multi-intercellular exchanges and serial trogocytosis (2010) (24)
- Tolerogenic Function of Dimeric Forms of HLA-G Recombinant Proteins: A Comparative Study In Vivo (2011) (24)
- Soluble human leukocyte antigen -G during pregnancy and infancy in Benin: Mother/child resemblance and association with the risk of malaria infection and low birth weight (2017) (22)
- Genetic and epigenetic features in radiation sensitivity (2005) (21)
- Ionizing radiation modulates the surface expression of human leukocyte antigen-G in a human melanoma cell line. (2009) (21)
- Genetic and epigenetic features in radiation sensitivity. Part II: implications for clinical practice and radiation protection. (2005) (21)
- Pseudomonas aeruginosa Quorum Sensing Molecule N-(3-Oxododecanoyl)-l-Homoserine-Lactone Induces HLA-G Expression in Human Immune Cells (2015) (20)
- Trogocytic intercellular membrane exchanges among hematological tumors (2015) (20)
- Aplastic anaemia and paroxysmal nocturnal haemoglobinuria: a study of the GPI‐anchored proteins on human platelets (1996) (20)
- Human CDK10 gene isoforms. (2000) (19)
- [HLA-G: immunoregulatory molecule involved in allograft acceptance]. (2003) (19)
- HLA-G: Public ligand for natural killer cell inhibitory receptors (1997) (18)
- Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary (2020) (18)
- HLA-G: a look back, a look forward (2011) (18)
- HLA‐G inhibition of NK‐cell cytolytic function is uncoupled from tumor cell lipid raft reorganization (2012) (17)
- The genetic diversity within the 1.4 kb HLA-G 5′ upstream regulatory region moderately impacts on cellular microenvironment responses (2018) (17)
- HLA-G/LILRBs: A Cancer Immunotherapy Challenge. (2021) (17)
- The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors. (2000) (16)
- HLA-G5 expression by trophoblast cells: the facts. (2005) (16)
- The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma (2020) (16)
- The HLA-G non classical MHC class I molecule is expressed in cancer with poor prognosis. Implications in tumour escape from immune system and clinical applications (2011) (16)
- Role of HLA-G in innate immunity through direct activation of NF-kappaB in natural killer cells. (2008) (15)
- Radiation-induced up-regulation of telomerase in KG1a cells is influenced by dose-rate and radiation quality (2002) (15)
- Chimerism in scleroderma (1998) (15)
- The Autoimmune Regulator (Aire) transactivates HLA‐G gene expression in thymic epithelial cells (2019) (14)
- Expression of nonclassical molecule human leukocyte antigen-G in oral lesions. (2012) (14)
- Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment (2015) (14)
- Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG’s receptor ILT2 on peripheral CD8+ T cells (2018) (14)
- Specific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver. (1998) (14)
- Study of cord blood natural killer cell suppressor activity (2001) (14)
- Increased sHLA-G Is Associated with Improved COVID-19 Outcome and Reduced Neutrophil Adhesion (2021) (13)
- Role of HLA-G in maternal-fetal immune tolerance. (1999) (13)
- HLA-G gene polymorphism segregation within CEPH reference families. (1997) (13)
- Ionizing radiation effects on the KG1a primitive hematopoietic cell line. (1996) (13)
- Endoplasmic Reticulum Calcium Pumps and Tumor Cell Differentiation (2020) (12)
- HLA-G mRNA forms in human trophoblasts and peripheral blood lymphocytes: potential use in prenatal diagnosis. (1994) (12)
- Expression and differential regulation of HLA-G isoforms in the retinal pigment epithelial cell line, ARPE-19. (2017) (12)
- [Alternative transcripts of the MHC of the non-classical class I HLA-G gene in the in trophoblast during the first pregnancy trimester and in the placenta at term]. (1995) (12)
- Progress of HLA-G in cancer. (2003) (12)
- Immunomodulation of classical and non-classical HLA molecules by ionizing radiation. (2016) (11)
- Natural killer cells are the unique lymphocyte cell subset which do not express HLA-G. (1995) (11)
- Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G (2019) (11)
- Langerhans' cells are depleted in chronic graft versus host disease. (1997) (11)
- [HLA-G: fetomaternal tolerance]. (2000) (10)
- Cytometry-based analysis of HLA-G functions according to ILT2 expression. (2020) (10)
- Role of the HLA-G immune checkpoint molecule in pregnancy. (2021) (10)
- Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets (2020) (10)
- Functional role of PECAM-1/CD31 molecule expressed on human cord blood progenitors. (1996) (10)
- High level of soluble human leukocyte antigen (HLA)-G at beginning of pregnancy as predictor of risk of malaria during infancy (2019) (9)
- Cord blood-endothelial colony forming cells are immunotolerated and participate at post-ischemic angiogenesis in an original dorsal chamber immunocompetent mouse model (2020) (8)
- Tumor infiltrating and peripheral CD4+ILT2+ T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients. (2021) (8)
- Increased soluble human leukocyte antigen-G levels in peripheral blood from climbers on Mount Everest. (2010) (7)
- Cellular co-localization of intron-4 containing mRNA and HLA-G soluble protein in melanoma analyzed by fluorescence in situ hybridization. (2007) (7)
- definitive hematopoiesis Erythroblasts secrete the nonclassical HLA-G molecule from primitive to (2013) (7)
- Transplacental transmission of natural-killer-cell lymphoma. (1999) (7)
- Immunotherapy in Urologic Cancer : Evolving Roles for Targeting of CTLA-4 , PD-1 / PD-L 1 , and HLA-G (2015) (7)
- [Fetomaternal tolerance: role of HLA-G molecule in the protection of the fetus against maternal natural killer activity]. (1997) (7)
- Inhibition of T Cell Alloreactivity by Bronchial Epithelium Is Impaired in Lung Transplant Recipients, Through Pathways Involving TGF-&bgr;, IL-10 and HLA-G (2017) (6)
- Human Keratinocytes Inhibit CD4+ T-Cell Proliferation through TGFB1 Secretion and Surface Expression of HLA-G1 and PD-L1 Immune Checkpoints (2021) (6)
- [Cutaneous manifestations of graft versus host reaction]. (1998) (6)
- Wound Healing by Allogeneic Transplantation of Specific Subpopulation From Human Umbilical Cord Mesenchymal Stem Cells (2021) (6)
- Pharmacological inhibition of DNA repair enzymes differentially modulates telomerase activity and apoptosis in two human leukaemia cell lines (2004) (6)
- Human Leukocyte Antigen-G: Immunotolerant Major Histocompatibility Complex Molecule in Transplantation (2000) (5)
- HLA-G expression during hookworm infection in pregnant women. (2019) (5)
- From MAC to HLA: Professor Jean Dausset, the pioneer. (2009) (5)
- HLA-G mediates protection from natural killer cytolysis: implications in immune tolerance. (1999) (5)
- [HLA-G: immune tolerance in normal and pathological physiology]. (2002) (5)
- Soluble HLA-G induces NF–кB activation in natural killer cells (2010) (5)
- Influence of hormones on the immunotolerogenic molecule HLA-G: a cross-sectional study in patients with congenital adrenal hyperplasia. (2019) (5)
- Hematopoiesis research in aplastic anaemia induced by accidental protracted radiation. (1996) (5)
- HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma (2017) (5)
- Lymphocytes, cytokines and adhesion molecules in chronic graft versus host disease (1996) (5)
- HLA-G1 increases the radiosensitivity of human tumoral cells. (2014) (5)
- [Telomeres and genomic damage repair. Their implication in human pathology]. (2002) (4)
- The HLA-G immune checkpoint: a new immuno-stimulatory role for the α1-domain-deleted isoform (2022) (4)
- molecule Beyond the increasing complexity of the immunomodulatory HLA-G (2013) (4)
- [HLA-G: a non classical antigen of major histocompatibility complex]. (1995) (3)
- HLA-G liver expression and HLA-G extended haplotypes are associated with chronic hepatitis C in HIV-negative and HIV-coinfected patients. (2020) (3)
- Acquired Aplastic Anaemia (1995) (3)
- Erratum to: Inhibition of human gamma delta T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer (2011) (3)
- Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation (2016) (3)
- cells The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory (2012) (3)
- HLA-G gene editing in tumor cell lines as a novel alternative in cancer immunotherapy (2021) (3)
- Placental Malaria is Associated with Higher LILRB2 Expression in Monocyte Subsets and Lower Anti-Malarial IgG Antibodies During Infancy (2022) (2)
- Human Leukocyte Antigen-G Is Frequently Expressed in Glioblastoma and May Be Induced inVitro by Combined 5-Aza-2-Deoxycytidine and Interferon- Treatments (2)
- Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with papillary transitional cell carcinoma of the bladder (2010) (2)
- Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G. (2022) (2)
- Multiplex bead-based immunoassay for the free soluble forms of the HLA-G receptors, ILT2 and ILT4. (2016) (2)
- Methods for Establishing a Renal Cell Carcinoma Tumor Spheroid Model With Immune Infiltration for Immunotherapeutic Studies (2022) (2)
- HLA-G Antigen Expression in Renal Carcinoma Tumor-specific Up-Regulation of the Nonclassical Class I Updated (2001) (2)
- [HLA-G in organ transplantation]. (2004) (2)
- Delineation of human cord blood hematopoietic progenitor cell subsets with a unique monoclonal antibody AY19. (1998) (1)
- Expression of HLA-G in the retinal pigment epithelial cell line, ARPE-19 (2014) (1)
- High level of soluble human leukocyte antigen (HLA)-G at beginning of pregnancy as predictor of risk of malaria during infancy (2019) (1)
- HLA-G: a new opening for HLA. (1999) (1)
- Cord blood-endothelial colony forming cells are immunotolerated and participate at post-ischemic angiogenesis in an original dorsal chamber immunocompetent mouse model (2020) (1)
- Extended HLA‐G haplotypes in patients with age‐related macular degeneration (2018) (1)
- Immunosuppressive Properties of Epidermal Keratinocytes Differ According to Their Immaturity Status (2022) (1)
- override GvL effect transplants: immaturity of NK cells and inhibitory effect of NKG2A NK cell reconstitution after haploidentical hematopoietic stem cell (2013) (1)
- [HLA-G: a tolerance molecule implicated in the escape of tumors from immunosurveillance]. (1999) (1)
- Production and isolation of HLA-G1 and HLA-G5 soluble proteins in E. coli (1997) (1)
- Trogocytosis and NK Cells in Mouse and Man (2010) (1)
- CHIMERISM IN SCLERODERMA. AUTHORS' REPLY (1998) (1)
- Non-classical transcriptional regulation of HLA-G: an update (2010) (1)
- Role of HLA-G Expression as a Predictive Marker of a Low Risk of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients: A 3-Year Prospective Study (2013) (1)
- PO-0984: Checkpoint HLA-G or its ligands ILT2/ILT4 changes radiosensitivity of renal carcinoma cell lines (2017) (0)
- Novel isoform of HLA-G and its applications (2000) (0)
- HLA-G mRNA alternatively spliced forms that may encoded at least five distinct molecules on the cell surface (1997) (0)
- Special Issue: Trends in HLA-G Research (2007) (0)
- Opening address to the 6th International Conference on HLA-G. (2013) (0)
- The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma (2020) (0)
- LILRB1 and LILRB2 expression in peripheral blood immune cells at 18 and 24 months of age in infants born from mothers with placental malaria (2021) (0)
- CTLA 4-Ig Treatment : Implication in Human Immunosuppressive HLA-G Molecule upon Dendritic Cells Secrete the and (2009) (0)
- Telomerase and apoptosis in human hematopoietic cell lines: modulation of the radiation response by pharmacological inhibition of DNA repair enzymes (2004) (0)
- Late Breaking Abstract - Prediction of chronic lung allograft rejection (CLAD) by measurement of peripheral T cells linked to the inhibitory check-point HLA-G (2020) (0)
- Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors (2012) (0)
- Regulation and modulation of classical HLA class I gene transcription in trophoblast cells and choriocarcinoma JEG-3 cells (1997) (0)
- Transcriptional regulation of the HLA-G gene: Cell specific nuclear factors bind to a 5′ regulatory element located at 1.1 kb to the translation site of HLA-G gene (1997) (0)
- Transcript 2 Receptor Suppresses B Cell Binding of HLA-G to ITIM-Bearing Ig-like Pistoia (2014) (0)
- Altered Immunosuppressive Properties of Lung Transplant Recipients’ Bronchial Epithelium: An Ex-Vivo Model of T-Allogenic Response (2015) (0)
- Tumor Heterogeneity Uncovered by HLA-G Isoforms Expression (2019) (0)
- Polypeptides multimers HLA-G comprising at least two domains alpha3 and pharmaceutical uses thereof (2010) (0)
- Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria: Search (2002) (0)
- HLA-G gene editing: a novel therapeutic alternative in cancer immunotherapy (2021) (0)
- Polypeptides multimeric HLA-G alpha1-monomers including alpha3 and pharmaceutical uses thereof (2010) (0)
- P375 - BY55 monoclonal antibody identify a novel NK cell receptor (1996) (0)
- Gentranscripte of MHC class I HLA-G and their uses (1995) (0)
- Prédiction de la dysfonction chronique du greffon (CLAD) par la mesure des lymphocytes T CD4+CD57+ILT2+ liés au checkpoint inhibiteur HLA-G (2021) (0)
- 458: A single-centre retrospective study on human leukocyte antigen-G expression in heart transplant recipients prior to, during, and following episodes of rejection (2007) (0)
- HLA-G1 and HLA-G2 act as ligands recognized by a yet-unknown natural killer inhibitory receptor(s) (1997) (0)
- Role of NK cells relevant to cord blood transplantation (1997) (0)
- Expression of HLA-G1 and HLA-G2 isoforms on the K562 transfected cells (1997) (0)
- Pathogenesis of cutaneous graft versus host disease (1997) (0)
- Dataset for: Novel landscape of HLA-G isoforms in clear cell renal cell carcinoma patients (2017) (0)
- Isoforme d'hla-g (hla-g7) et ses applications (2001) (0)
- graft versus host disease . Langerhans ' cells are depleted in chronic (0)
- Cell Transfer of Sensitivity - after Trogocytosis Allows a Functional Cell Proper Regrafting of Ig-Like Transcript 2 (2011) (0)
- Langerhans cells are depleted in chronic GvHD (1997) (0)
- Induction of CD4+ regulatory T cells by soluble HLA-G isoforms. (2012) (0)
- Anti-human interleukin 2 receptor monoclonal antibody isotypic switching: chimeric rat-human antibodies. (1990) (0)
- The genetic diversity within the 1.4 kb HLA-G 5′ upstream regulatory region moderately impacts on cellular microenvironment responses (2018) (0)
- Trends in HLA-G research. Editorial. (2009) (0)
- A method for HLA-G analysis by sequencing based typing (2003) (0)
- [Culture and scientific research. A binomial to preserve]. (1999) (0)
- Responses2 Receptor Suppresses B Cell Binding of HLA-G to ITIM-Bearing Ig-like (2014) (0)
- Cytolysis Inhibit NK and Antigen-Specific CTL as Nonmature Cell Surface Glycoproteins HLA-G 2 ,-G 3 , and-G 4 Isoforms Expressed (2001) (0)
- PML is expressed in chronic GvHD (1997) (0)
- Forthcoming papers (2005) (0)
- Use of compositions containing soluble forms of HLA-G in the treatment of inflammatory diseases of the skin, and process for obtaining them (1999) (0)
- Immunosuppressive/ Regulatory T Cells Allograft Acceptance through Induction of Evidence to Support the Role of HLA-G5 in (0)
- Hla-g (hla-g7) isoform and its applications (2001) (0)
- Transcripts of the HLA-G gene of the major histocompatibility complex (MHC) class 1, and their applications (1995) (0)
- Evidence of indirect allorecognition of HLA /non-HLA antigens expressed by bronchial epithelial cells from lung transplant recipients (2016) (0)
- Transcripts of MHC class I gene HLA-G and their applications. (1994) (0)
- Correction for Bortolotti et al., “Pseudomonas aeruginosa Quorum Sensing Molecule N-(3-Oxododecanoyl)-l-Homoserine-Lactone Induces HLA-G Expression in Human Immune Cells” (2017) (0)
- Short title : Association of HLA-G*0106 with pregnancy diseases Summary sentence : HLA-G*0106 allele frequency is enhanced in placentas from pregnancy diseases such as pre-eclampsia and miscarriage Keywords and Topic Category : HLA-G, polymorphism, placenta, pregnancy disease. (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Edgardo Delfino Carosella?
Edgardo Delfino Carosella is affiliated with the following schools:
